Ulrike Jahnke, Editor at Thomson Reuters, discusses insights from the Evidence and the Pharma Pricing & Market Access Outlook Europe 2014 meetings and why it is essential for the pharma industry to start early with its market access strategy, work with payers and clearly demonstrate the value of a novel drug to society. The growth […]
written on 20.03.2014
Market Insight: The Use of Real-World Evidence is a Must for Gaining Market Access
